1. MiR-204 inhibits the proliferation and invasion of renal cell carcinoma by inhibiting RAB22A expression.
   Feng Xiong et al, 2016, Oncol Rep CrossRef
2. Biomarkers of Cancer
   Kewal K. Jain, 2017 CrossRef
3. Noncoding RNA Expression and Targeted Next-Generation Sequencing Distinguish Tubulocystic Renal Cell Carcinoma (TC-RCC) from Other Renal Neoplasms
   Charles H. Lawrie et al, 2017, The Journal of Molecular Diagnostics CrossRef
4. Prognostic and predictive miRNA biomarkers in bladder, kidney and prostate cancer: Where do we stand in biomarker development?
   Maria Schubert et al, 2016, J Cancer Res Clin Oncol CrossRef
5. MiR-32 functions as a tumor suppressor and directly targets EZH2 in human oral squamous cell carcinoma.
   Dafeng Zhang et al, 2014, Med. Sci. Monit. CrossRef
6. miR-490-5p suppresses tumour growth in renal cell carcinoma through targeting PIK3CA.
   Ke Chen et al, 2016, Biol Cell CrossRef
7. The relationship between and clinical significance of MicroRNA-32 and phosphatase and tensin homologue expression in colorectal cancer
   Weiyun Wu et al, 2013, Genes Chromosomes Cancer CrossRef
8. MicroRNA profiles classify papillary renal cell carcinoma subtypes.
   S Wach et al, 2013, Br. J. Cancer CrossRef
9. New miRNA Profiles Accurately Distinguish Renal Cell Carcinomas and Upper Tract Urothelial Carcinomas from the Normal Kidney
   Apostolos Zaravinos et al, 2014, PLoS ONE CrossRef
10. Targeted next-generation sequencing and non-coding RNA expression analysis of clear cell papillary renal cell carcinoma suggests distinct pathological mechanisms from other renal tumour subtypes
    Charles H Lawrie et al, 2014, J. Pathol. CrossRef
11. Nucleic acid-based tissue biomarkers of urologic malignancies
    Dimo Dietrich et al, 2014, Critical Reviews in Clinical Laboratory Sciences CrossRef
12. MicroRNA in prostate, bladder, and kidney cancer: a systematic review.
    James W F Catto et al, 2011, Eur. Urol. CrossRef
13. Regulatory feedback loop between T3 and microRNAs in renal cancer.
    Joanna Bogusławska, 0 CrossRef
14. The Role of MicroRNAs in Kidney Disease
    Sydwell Mukhadi et al, 2015, ncRNA CrossRef
15. microRNA-21 governs TORC1 activation in renal cancer cell proliferation and invasion.
    Nirmalya Dey et al, 2012, PLoS ONE CrossRef
16. Resistance to sunitinib in renal cell carcinoma: From molecular mechanisms to predictive markers and future perspectives.
    S C Joosten et al, 0 CrossRef
17. Papillary renal cell carcinoma: A review of the current therapeutic landscape.
    Giulia Courthod et al, 0 CrossRef
18. MicroRNA-32 promotes cell proliferation, migration and suppresses apoptosis in breast cancer cells by targeting FBXW7
    Wei Xia et al, 2017, Cancer Cell Int CrossRef
19. DNA Methylation and Urological Cancer, a Step Towards Personalized Medicine: Current and Future Prospects.
    Javier C Angulo et al, 2016, Mol Diagn Ther CrossRef
20. MicroRNA Expression Profiling in Clear Cell Renal Cell Carcinoma: Identification and Functional Validation of Key miRNAs.
    Haowei He et al, 2015, PLoS ONE CrossRef
21. Oncogenic micro-RNAs and Renal Cell Carcinoma.
    Cristina Grange et al, 2014, Front Oncol CrossRef
22. Altered expression of microRNA-203 in rheumatoid arthritis synovial fibroblasts and its role in fibroblast activation.
    Joanna Stanczyk et al, 2011, Arthritis Rheum. CrossRef
23. Identification of MicroRNAs associated with early relapse after nephrectomy in renal cell carcinoma patients.
    Ondrej Slaby et al, 0 CrossRef
24. Genome-wide microRNA expression analysis of clear cell renal cell carcinoma by next generation deep sequencing.
    Susanne Osanto et al, 0 CrossRef
25. Renal Carcinogenesis, Tumor Heterogeneity, and Reactive Oxygen Species: Tactics Evolved
    Karthigayan Shanmugasundaram et al, 2016, Antioxidants & Redox Signaling CrossRef
26. The epigenetic landscape of renal cancer
    Mark R. Morris et al, 2017, Nat Rev Nephrol CrossRef
27. MiR-224 targets the 3'UTR of type 1 5'-iodothyronine deiodinase possibly contributing to tissue hypothyroidism in renal cancer.
    Joanna Bogusławska, 0 CrossRef
28. microRNA-21-induced dissociation of PDCD4 from rictor contributes to Akt-IKKβ-mTORC1 axis to regulate renal cancer cell invasion.
    Amit Bera et al, 2014, Exp. Cell Res. CrossRef
29. Genomics and epigenomics of clear cell renal cell carcinoma: recent developments and potential applications.
    Małgorzata Rydzanicz et al, 2013, Cancer Lett. CrossRef
30. DNA methylation profiling distinguishes histological subtypes of renal cell carcinoma.
    Amy A Slater et al, 0 CrossRef
31. microRNAs in kidneys: biogenesis, regulation, and pathophysiological roles.
    Kirti Bhatt et al, 2011, Am. J. Physiol. Renal Physiol. CrossRef
32. Proliferation inhibition and the underlying molecular mechanisms of microRNA-30d in renal carcinoma cells
    HONGSHENG YU et al, 2014 CrossRef
33. MicroRNAs in the Pathogenesis of Renal Cell Carcinoma and Their Diagnostic and Prognostic Utility as Cancer Biomarkers
    Michal Fedorko et al, 2016, The International Journal of Biological Markers CrossRef
34. Clinical utility of microRNAs in renal cell carcinoma: current evidence and future perspectives
    Panagiotis Tsiakanikas et al, 2018, Expert Review of Molecular Diagnostics CrossRef
35. Potential application of tumor suppressor microRNAs for targeted therapy in head and neck cancer: A mini-review
    Isaac Olatunji, 2018, Oral Oncology CrossRef
36. A Machine Learning Approach for the Classification of Kidney Cancer Subtypes Using miRNA Genome Data
    Ali Muhamed Ali et al, 2018, Applied Sciences CrossRef
37. Expression of miRNA-106b in conventional renal cell carcinoma is a potential marker for prediction of early metastasis after nephrectomy.
    Ondrej Slaby et al, 2010, J. Exp. Clin. Cancer Res. CrossRef
38. Clinical Research in the Postgenomic Era
    Stephane M. Meystre et al, 2019 CrossRef
39. MicroRNAs in Predicting Radiotherapy and Chemotherapy Response
    Emily J. Noonan et al, 2011 CrossRef
40. Clinical Research in the Postgenomic Era
    Stephane M. Meystre et al, 2012 CrossRef
41. The significance of gene mutations across eight major cancer types
    Prosenjit Paul et al, 2019, Mutation Research/Reviews in Mutation Research CrossRef
42. Kidney Cancer Genomics: Paving the Road to a New Paradigm of Personalized Medicine
    George M. Yousef et al, 2013 CrossRef
43. Epigenetics and MicroRNAs in Renal Cancer
    Shahana Majid et al, 2013 CrossRef
44. Biomarkers of Cancer
    Kewal K. Jain, 2014 CrossRef
45. MicroRNAs in the Development and Progression of Kidney Cancer
    Sharanjot Saini et al, 2014 CrossRef
46. MiR-32 Inhibits Proliferation and Metastasis by Targeting EZH2 in Glioma
    Yuan Zhang et al, 2019, Technol Cancer Res Treat CrossRef
47. 4-miRNA Score Predicts the Individual Metastatic Risk of Renal Cell Carcinoma Patients
    Joana Heinzelmann et al, 2019, Ann Surg Oncol CrossRef
48. Current Concepts of Non-Coding RNAs in the Pathogenesis of Non-Clear Cell Renal Cell Carcinoma
    Dominik A. Barth et al, 2019, Cancers CrossRef
49. Genomic analysis of microRNA time-course expression in liver of mice treated with genotoxic carcinogen N-ethyl-N-nitrosourea
    Zhiguang Li et al, 2010, BMC Genomics CrossRef
50. Transcriptomics in RCC
    Jamil S. Syed et al, 2020, Urologic Oncology: Seminars and Original Investigations CrossRef
51. Integrated genomic analysis identifies subclasses and prognosis signatures of kidney cancer
    Yann Christinat et al, 2015, Oncotarget CrossRef
52. Anti-angiogenesis and Immunotherapy: Novel Paradigms to Envision Tailored Approaches in Renal Cell-Carcinoma
    Antonella Argentiero et al, 2020, JCM CrossRef
53. Comparison of exosomal microRNAs secreted by 786‑O clear cell renal carcinoma cells and HK‑2 proximal tubule‑derived cells in culture identifies microRNA‑205 as a potential biomarker of clear cell renal carcinoma
    Victor Crentsil et al, 2018, Oncol Lett CrossRef
54. Personal Medicine and Bone Metastases: Biomarkers, Micro-RNAs and Bone Metastases
    Steven L. Wood et al, 2020, Cancers CrossRef
55. Identification of RCC Subtype-Specific microRNAs-Meta-Analysis of High-Throughput RCC Tumor microRNA Expression Data.
    Arkadiusz Kajdasz et al, 2021, Cancers (Basel) CrossRef
56. MicroRNAs as predictive biomarkers of response to tyrosine kinase inhibitor therapy in metastatic renal cell carcinoma
    Julia Kovacova et al, 2018 CrossRef
57. The Role of Epigenetics in the Progression of Clear Cell Renal Cell Carcinoma and the Basis for Future Epigenetic Treatments
    Javier C. Angulo et al, 2021, Cancers CrossRef
58. MiR-32 Suppresses the Development of Lung Cancer via Modulating PI3K/Akt
    Qing-Feng Liu et al, 2021, j biomater tissue eng CrossRef
59. MicroRNA-32 (miR-32) regulates phosphatase and tensin homologue (PTEN) expression and promotes growth, migration, and invasion in colorectal carcinoma cells
    Weiyun Wu et al, 2013, Mol Cancer CrossRef
60. Expression analysis and in silico characterization of intronic long noncoding RNAs in renal cell carcinoma: emerging functional associations
    Angela A Fachel et al, 2013, Mol Cancer CrossRef
61. Identifying mRNA targets of microRNA dysregulated in cancer: with application to clear cell Renal Cell Carcinoma
    Huiqing Liu et al, 2010, BMC Syst Biol CrossRef
62. MicroRNA as a Biomarker for Diagnostic, Prognostic, and Therapeutic Purpose in Urinary Tract Cancer
    Amro M. Soliman et al, 2021, Processes CrossRef
63. MiRNAs in renal cell carcinoma
    Jesús Miranda-Poma et al, 2022, Clin Transl Oncol CrossRef
64. Construction and validation of a novel ten miRNA-pair based signature for the prognosis of clear cell renal cell carcinoma
    Yulin Wang et al, 2022, Translational Oncology CrossRef
65. Epigenetics in advanced renal cell carcinoma: potential new targets
    Javier Molina-Cerrillo et al, 2022, Critical Reviews in Oncology/Hematology CrossRef
66. The Role of miRNA in the Management of Localized and Advanced Renal Masses, a Narrative Review of the Literature
    Luigi Napolitano et al, 2022, Applied Sciences CrossRef
67. Genome-wide Discovery of MicroRNA Biomarkers for Cancer Precision Medicine
    Zhongxu Zhu et al, 2020 CrossRef
68. miRNAs as potential game-changers in renal cell carcinoma: Future clinical and medicinal uses
    Mohammed S. Elballal et al, 2023, Pathology - Research and Practice CrossRef
69. Inflammation- and cancer-related microRNAs in rat renal cortex after subchronic exposure to fluoride
    Benjamín Parada-Cruz et al, 2023, Chemico-Biological Interactions CrossRef
70. Molecular, Genetic, and Other Omics Data
    Stephane M. Meystre et al, 2023 CrossRef
71. The role of natural products versus miRNA in renal cell carcinoma: implications for disease mechanisms and diagnostic markers
    Abdullah Ayed, 2024, Naunyn-Schmiedeberg's Arch Pharmacol CrossRef
72. MicroRNAs in Genitourinary Malignancies: An Exciting Frontier of Cancer Diagnostics and Therapeutics
    Nikhita Kathuria-Prakash et al, 2024, IJMS CrossRef